Your browser doesn't support javascript.
loading
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial.
Oaknin, Ana; Moore, Kathleen; Meyer, Tim; López-Picazo González, José; Devriese, Lot A; Amin, Asim; Lao, Christopher D; Boni, Valentina; Sharfman, William H; Park, Jong Chul; Tahara, Makoto; Topalian, Suzanne L; Magallanes, Manuel; Molina Alavez, Alejandro; Khan, Tariq Aziz; Copigneaux, Catherine; Lee, Michelle; Garnett-Benson, Charlie; Wang, Xuya; Naumann, R Wendel.
Afiliación
  • Oaknin A; Medical Oncology Service, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. Electronic address: aoaknin@vhio.net.
  • Moore K; Stephenson Cancer Center, Oklahoma City, OK, USA; Sarah Cannon Research Institute, Nashville, TN, USA.
  • Meyer T; University College London, London, UK.
  • López-Picazo González J; Clinica Universidad de Navarra, Navarra, Spain.
  • Devriese LA; Universitair Medisch Centrum Utrecht, Utrecht, Netherlands.
  • Amin A; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Lao CD; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.
  • Boni V; Medical Oncology, START Madrid, Centro Integral Oncológico Clara Campal, Hospital Madrid Norte Sanchinarro, Madrid, Spain.
  • Sharfman WH; Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy and Kimmel Cancer Center, Baltimore, MD, USA.
  • Park JC; Massachusetts General Hospital, Boston, MA, USA.
  • Tahara M; National Cancer Center Hospital East, Kashiwa, Japan.
  • Topalian SL; Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy and Kimmel Cancer Center, Baltimore, MD, USA.
  • Magallanes M; Centro Oncológico Internacional, Mexico City, Mexico.
  • Molina Alavez A; Centro de Atención e Investigación Clínica en Oncología, Mérida, Mexico.
  • Khan TA; Bristol Myers Squibb, Princeton, NJ, USA.
  • Copigneaux C; Bristol Myers Squibb, Princeton, NJ, USA.
  • Lee M; Bristol Myers Squibb, Princeton, NJ, USA; Syneos Health, Morrisville, NC, USA.
  • Garnett-Benson C; Bristol Myers Squibb, Princeton, NJ, USA.
  • Wang X; Bristol Myers Squibb, Princeton, NJ, USA.
  • Naumann RW; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Lancet Oncol ; 25(5): 588-602, 2024 May.
Article en En | MEDLINE | ID: mdl-38608691
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 3_diarrhea / 4_diarrhoeal_infections / 6_cervical_cancer Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Cuello Uterino / Ipilimumab / Nivolumab / Recurrencia Local de Neoplasia Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 3_diarrhea / 4_diarrhoeal_infections / 6_cervical_cancer Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Cuello Uterino / Ipilimumab / Nivolumab / Recurrencia Local de Neoplasia Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article